QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: GVP Module VII — PSUR Reference Data and International Safety Information

Test your understanding of the concepts covered by GVP Module VII: PSUR Reference Data and International Safety Information.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A country outside the EU shows a large increase in adverse-event reports. Which interpretation is most appropriate initially?

The EU risk has increased by the same proportion The increase is irrelevant because it occurred outside the EU The increase should be evaluated with exposure, reporting behaviour, case characteristics, local use patterns and mechanistic relevance The increase proves that a new EU contraindication is required

Question 2 of 10 Which practice best demonstrates that international information was appropriately assessed when it was excluded from a PSUR conclusion?

Relying on the absence of EU reports as the exclusion rationale Documenting the scientific and regulatory reasons why the finding was not applicable to the EU product or assessment Removing the finding from all internal safety systems Recording only that the information came from a non-EU source

Question 3 of 10 What is the main inspection concern when a PSUR uses a reference document but cannot show why it was selected?

The document may be too short for a PSUR The organisation lacks evidence that the baseline was appropriate, controlled and traceable to the assessment The document must be replaced by a global core document in all cases The PSUR cannot contain any international safety information

Question 4 of 10 A foreign literature report concerns a population receiving a different dose and treatment duration from the EU-authorised use. What is the best assessment approach?

Exclude it solely because it is foreign Apply it directly to all EU patients without qualification Assess the product, dose, population, outcome, exposure and methodological limitations before determining its relevance Count it as an EU case only if it appears in the global database

Question 5 of 10 Which statement best describes the relationship between expectedness and clinical importance?

An expected reaction cannot be clinically important Expectedness determines causality and therefore determines the benefit-risk conclusion A reaction may be serious and expected, and expectedness does not by itself determine causality or overall clinical importance An unexpected event is necessarily a new confirmed safety risk

Question 6 of 10 An important warning is added three months before the DLP following a regulatory safety assessment. Which PSUR approach best reflects the significance of the change?

Record only that the warning was present at the DLP Describe the earlier and later reference states, the evidence and regulatory basis for the change, its effective date, and its implications Assume the warning proves that the product's overall benefit-risk balance is negative Exclude the change because it occurred after the start of the reporting interval

Question 7 of 10 Which distinction between reference safety information and reference product information is most accurate?

Reference safety information addresses the established safety profile, while reference product information provides broader regulatory and clinical context such as authorised indications Reference safety information is used only for EU products, while reference product information is used only for non-EU products Reference product information determines expectedness, while reference safety information determines which indications are authorised The two terms are interchangeable whenever they appear in the same controlled document

Question 8 of 10 What is the primary analytical purpose of reference information in a PSUR?

To provide a controlled baseline against which safety findings and changes in the safety profile are evaluated To list every product-information document used by the MAH worldwide To replace cumulative case assessment with a comparison against the product label To determine automatically whether the product remains authorised in each jurisdiction

Question 9 of 10 Which principle should guide the inclusion of international safety information in an EU PSUR?

Include only information originating from EU Member States Include information based on its scientific, clinical and regulatory relevance to the EU product and assessment Include every foreign regulatory action as an EU product-information change Exclude international findings when no corresponding EU individual case has been received

Question 10 of 10 Which statement best describes the relationship between changes to the RMP and changes to reference safety information?

Every RMP change automatically requires a product-information change Every product-information change automatically requires an RMP change They may be related but are not synonymous; evidence and regulatory decisions determine what changes occur Neither type of change needs to be considered in a PSUR

Knowledge Assessment: GVP Module VII — PSUR Reference Data and International Safety Information

Cookie Settings